Learn About Central Serous Chorioretinopathy
- Central serous chorioretinopathy
- Central serous chorioretinopathy after bone marrow transplantation
- Central serous choroidopathy
Vitreous Retina Macula Consultants Of New York
Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Centre Hospitalier Intercommunal Creteil University Paris Est
Giuseppe Querques practices in Creteil, France. Mr. Querques is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.
Sascha Fauser practices in Koeln, Germany. Fauser is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. Their top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Vitrectomy, and Cataract Removal.
Summary: To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone
Summary: To investigate the potential association between gut microbiota and central serous chorioretinopathy (CSC), we have observed in our clinical practice that CSC patients often experience chronic gastrointestinal issues. This observation has led us to hypothesize that CSC may be associated with gut dysbiosis. The Bifidobacterium genus is widely recognized as a beneficial gut bacterium, and numerous w...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center